Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Health Sciences profile

Dr Christopher Jackson

PositionConsultant Medical Oncologist
DepartmentDepartment of Medicine (DSM)
QualificationsMB ChB FRACP
Research summaryGastrointestinal cancers, particularly colorectal cancer; clinical trials in cancer.
ClinicalGastrointestinal cancer, lymphoma, melanoma, genitourinary cancer.

Research

Clinical aspects of Colorectal Cancer and its management, as well as health services research. Collaborating with lab-based scientists on genetic aspects of cancer, treatment and toxicity, as well as immunotherapy in a variety of solid tumours.

Publications

Segelov, E., Chan, D., Lawrence, B., Pavlakis, N., Kennecke, H. F., Jackson, C., … Singh, S. (2017). Identifying and prioritizing gaps in neuroendocrine tumor research: A modified Delphi process with patients and health care providers to set the research action plan for the newly formed Commonwealth Neuroendocrine Tumor Collaboration. Journal of Global Oncology, 3(4), 380-388. doi: 10.1200/jgo.2016.006916

Grant, M. L., Shields, N., Neumann, S., Kramer, K., Bonato, A., Jackson, C., Baird, M. A., & Young, S. L. (2017). Combining dendritic cells and B cells for presentation of oxidised tumour antigens to CD8+ T cells. Clinical & Translational Immunology, 6, e149. doi: 10.1038/cti.2017.28

Tiong, J., Gray, A., Jackson, C., Thompson-Fawcett, M., & Schultz, M. (2017). Audit of the association between length of time spent on diagnostic work-up and tumour stage in patients with symptomatic colon cancer. ANZ Journal of Surgery, 87(3), 138-142. doi: 10.1111/ans.12804

Lim, Y. K., Jackson, C., Dauway, E. L., & Richter, K. K. (2017). Risk factors for adverse outcome for elderly patients undergoing curative oncological resection for gastrointestinal malignancies. Visceral Medicine, 33(4). doi: 10.1159/000475938

Li, K., Baird, M., Yang, J., Jackson, C., Ronchese, F., & Young, S. (2016). Conditions for the generation of cytotoxic CD4+ Th cells that enhance CD8+ CTL-mediated tumor regression. Clinical & Translational Immunology, 5(8), e95. doi: 10.1038/cti.2016.46

Journal - Research Article

Segelov, E., Chan, D., Lawrence, B., Pavlakis, N., Kennecke, H. F., Jackson, C., … Singh, S. (2017). Identifying and prioritizing gaps in neuroendocrine tumor research: A modified Delphi process with patients and health care providers to set the research action plan for the newly formed Commonwealth Neuroendocrine Tumor Collaboration. Journal of Global Oncology, 3(4), 380-388. doi: 10.1200/jgo.2016.006916

Tiong, J., Gray, A., Jackson, C., Thompson-Fawcett, M., & Schultz, M. (2017). Audit of the association between length of time spent on diagnostic work-up and tumour stage in patients with symptomatic colon cancer. ANZ Journal of Surgery, 87(3), 138-142. doi: 10.1111/ans.12804

Grant, M. L., Shields, N., Neumann, S., Kramer, K., Bonato, A., Jackson, C., Baird, M. A., & Young, S. L. (2017). Combining dendritic cells and B cells for presentation of oxidised tumour antigens to CD8+ T cells. Clinical & Translational Immunology, 6, e149. doi: 10.1038/cti.2017.28

Li, K., Baird, M., Yang, J., Jackson, C., Ronchese, F., & Young, S. (2016). Conditions for the generation of cytotoxic CD4+ Th cells that enhance CD8+ CTL-mediated tumor regression. Clinical & Translational Immunology, 5(8), e95. doi: 10.1038/cti.2016.46

Firth, M. J., Sharples, K. J., Hinder, V. A., Macapagal, J., Sarfati, D., Derrett, S. L., … Atmore, C., Keating, J. P., Jeffery, M., … Jackson, C. G. C. A., & Findlay, M. P. N. (2016). Methods of a national colorectal cancer cohort study: The PIPER Project. New Zealand Medical Journal, 129(1440), 25-36. Retrieved from https://www.nzma.org.nz/journal

Sarfati, D., Koczwara, B., & Jackson, C. (2016). The impact of comorbidity on cancer and its treatment. CA: A Cancer Journal for Clinicians, 66(4), 337-350. doi: 10.3322/caac.21342

Stairmand, J., Signal, L., Sarfati, D., Jackson, C., Batten, L., Holdaway, M., & Cunningham, C. (2015). Consideration of comorbidity in treatment decision making in multidisciplinary cancer team meetings: A systematic review. Annals of Oncology, 26, 1325-1332. doi: 10.1093/annonc/mdv025

Jackson, C. G. C. A., Sharples, K., Thompson, P. I., O'Donnell, A., Robinson, B. A., Perez, D. J., … Findlay, M. P. (2014). Dose-intense capecitabine, oxaliplatin and bevacizumab as first line treatment for metastatic, unresectable colorectal cancer: A multi-centre phase II study. BMC Cancer, 14, 737. doi: 10.1186/1471-2407-14-737

Moorcraft, S. Y., Chau, I., Peckitt, C., Cunningham, D., Rao, S., Yim, K. L., … Jackson, C. G. C. A., … Swanton, C. (2013). Patupilone in patients with pretreated metastatic/locally recurrent colorectal cancer: Results of the Phase II CINATRA trial. Investigational New Drugs, 31(5), 1339-1344. doi: 10.1007/s10637-013-9990-3

Bidwell, S., Simpson, A., Sullivan, R., Robinson, B., Thomas, W., Jackson, C., … Clarke, T. (2013). A workforce survey of New Zealand medical oncologists. New Zealand Medical Journal, 126(1371). Retrieved from http://www.nzma.org.nz/journal

Pullar, J. M., Chisholm, A., & Jackson, C. (2012). Dietary information for colorectal cancer survivors: An unmet need. New Zealand Medical Journal, 125(1356). Retrieved from http://www.nzma.org.nz/journal

Richter, K. K., Dempster, A., Tos, A. P. D., Premkumar, R., & Jackson, C. (2011). Challenging differential diagnosis of a wild-type gastrointestinal stromal tumour (GIST) or rare reticular perineurioma of the stomach? The role for mutational analysis. New Zealand Medical Journal, 124(1331). Retrieved from http://journal.nzma.org.nz/journal/124-1331/4583/content.pdf

Jackson, C., Sirohi, B., Cunningham, D., Horwich, A., Thomas, K., & Wotherspoon, A. (2010). Lymphocyte-predominant Hodgkin lymphoma: Clinical features and treatment outcomes from a 30-year experience. Annals of Oncology, 21(10), 2061-2068. doi: 10.1093/annonc/mdq063

Jackson, C., Cunningham, D., Oliveira, J., on behalf of the ESMO Guidelines Working Group. (2009). Gastric cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of Oncology, 20(Suppl. 4), iv34-iv36. doi: 10.1093/annonc/mdp119

Kong, G., Jackson, C., Koh, D. M., Lewington, V., Sharma, B., Brown, G., … Cook, G. J. R. (2008). The use of 18F-FDG PET/CT in colorectal liver metastases—comparison with CT and liver MRI. European Journal of Nuclear Medicine & Molecular Imaging, 35(7), 1323-1329. doi: 10.1007/s00259-008-0743-z

Jackson, C., & Cunningham, D. (2008). Where to position monoclonal antibodies in first-line treatment of advanced colorectal cancer. European Journal of Cancer, 44, 652-662. doi: 10.1016/j.ejca.2008.01.021

Jackson, C., Starling, N., Chua, Y. J., & Cunningham, D. (2007). Pharmacotherapy for oesophagogastric cancer. Drugs, 67(17), 2539-2556.

Jackson, C., Mochlinski, K., & Cunningham, D. (2007). Therapeutic options in gastric cancer: Neoadjuvant chemotherapy vs postoperative chemoradiotherapy. Oncology, 21(9), 1084-1087.

Hung, N. A., Jackson, C., Nicholson, M., & Highton, J. (2006). Pregnancy-related polymyositis and massive perivillous fibrin deposition in the placenta: Are they pathogenetically related? Arthritis & Rheumatism, 55(1), 154-156. doi: 10.1002/art.21710

^ Top of page

Journal - Research Other

Lim, Y. K., Jackson, C., Dauway, E. L., & Richter, K. K. (2017). Risk factors for adverse outcome for elderly patients undergoing curative oncological resection for gastrointestinal malignancies. Visceral Medicine, 33(4). doi: 10.1159/000475938

Jackson, C. G. C. A., & Sarfati, D. (2016). How 'modifiable' are 'modifiable risk factors' for cancer? New Zealand Medical Journal, 129(1447), 7-9. Retrieved from http://www.nzma.org.nz/journal

Jackson, C., Robinson, B., & Findlay, M. (2014). Cancer services to 2025 in New Zealand: Investing in research-driven quality care. New Zealand Medical Journal, 127(1395). Retrieved from http://www.nzma.org.nz/journal

Jackson, C., Ehrenberg, N., Frizelle, F., Sarfati, D., Balasingham, A., Pearse, M., … Bissett, I. (2014). Rectal cancer: Future directions and priorities for treatment, research and policy in New Zealand. New Zealand Medical Journal, 127(1395). Retrieved from http://www.nzma.org.nz/journal

Jackson, C., McCall, J., Robinson, B., Sharples, K., & Findlay, M. (2013). Cancer trials in New Zealand: Patients are not the problem. New Zealand Medical Journal, 126(1381). Retrieved from http://www.nzma.org.nz/journal

More publications...